Yasodha Natkunam, M.D., Ph.D

Professional Education

Medical Education: Mt Sinai School of Medicine (1995) NY

Internship: Stanford University School of Medicine (1996) CA

Residency: Stanford University School of Medicine (2000) CA

Board Certification: Anatomic Pathology, American Board of Pathology (1998)

PhD, Mt.Sinai School of Medicine, Molecular Biology (1993)

AB, Bryn Mawr College, Biology (1987)

Administrative Appointments

Associate Chair for Hematopathology, Stanford, 2009

Program Director, Hematopathology Fellowship, Stanford, 2009

Associate Chair for Faculty Development and Diversity, Stanford, 2009

Co-Director, Immunodiagnosis Laboratory, Stanford, 2005

Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation
Romero-Camarero, I., Jiang, X., Natkunam, Y., Lu, X., Vicente-Duenas, C., & Lossos, I. S. (2013). Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation. NATURE COMMUNICATIONS, 4.

Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404).
Ganjoo, K., Hong, F., Horning, S. J., Gascoyne, R. D., Natkunam, Y., & Advani, R. H. (2014). Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404). Leukemia & lymphoma, 55(4), 768-772.

Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Advani, R. H., Horning, S. J., Hoppe, R. T., Daadi, S., Allen, J., & Bartlett, N. L. (2014). Mature Results of a Phase II Study of Rituximab Therapy for Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Journal of clinical oncology , 32(9), 912-918.

LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype
Patel, J. L., Pournazari, P., Haggstrom, S.-J., Kosari, F., Shabani-Rad, M.-T., & Mansoor, A. (2014). LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype. HISTOPATHOLOGY, 64(2), 226-233.

Expression of the Activating Receptor, NKp46 (CD335), in Human Natural Killer and T-Cell Neoplasia.
Freud, A. G., Zhao, S., Wei, S., Gitana, G. M., Molina-Kirsch, H. F., & Natkunam, Y. (2013). Expression of the Activating Receptor, NKp46 (CD335), in Human Natural Killer and T-Cell Neoplasia. American journal of clinical pathology, 140(6), 853-866.

Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas
Zhu, D., Ikpatt, O. F., Dubovy, S. R., Lossos, C., Natkunam, Y., & Lossos, I. S. (2013). Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas. AMERICAN JOURNAL OF HEMATOLOGY, 88(9), 730-735.

LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas
Bertolo, C., Roa, S., Sagardoy, A., Mena-Varas, M., Robles, E. F., & Martinez-Climent, J. A. (2013). LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas. BRITISH JOURNAL OF HAEMATOLOGY, 162(5), 621-630.

CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma
Bhatt, S., Ashlock, B. M., Natkunam, Y., Sujoy, V., Chapman, J. R., & Lossos, I. S. (2013). CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma. BLOOD, 122(7), 1233-1242.

Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience.
Tan, D., Horning, S. J., Hoppe, R. T., Levy, R., Rosenberg, S. A., & Advani, R. H. (2013). Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood, 122(6), 981-987.

Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
Bürgesser, M. V., Gualco, G., Diller, A., Natkunam, Y., & Bacchi, C. E. (2013). Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina. Annals of diagnostic pathology, 17(3), 250-255.

Usefulness of HGAL and LMO2 Immunohistochemistry in the Identification of Follicular Lymphomas of the Non-Gastric Gastrointestinal Tract
Chapman-Fredricks, J., Younes, S. F., Fan, Y.-S., Sandoval-Sus, J. D., Natkunam, Y., & Lossos, I. S. (2013). Usefulness of HGAL and LMO2 Immunohistochemistry in the Identification of Follicular Lymphomas of the Non-Gastric Gastrointestinal Tract. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 21(3), 200-204.

Indolent T-Lymphoblastic Proliferation (iT-LBP): A Review of Clinical and Pathologic Features and Distinction from Malignant T-Lymphoblastic Lymphoma
Ohgami, R. S., Arber, D. A., Zehnder, J. L., Natkunam, Y., & Warnke, R. A. (2013). Indolent T-Lymphoblastic Proliferation (iT-LBP): A Review of Clinical and Pathologic Features and Distinction from Malignant T-Lymphoblastic Lymphoma. ADVANCES IN ANATOMIC PATHOLOGY, 20(3), 137-140.

The spectrum of lymphoblastic, nodal and extranodal T-cell lymphomas: characteristic features and diagnostic dilemmas
Savage, N. M., Johnson, R. C., & Natkunam, Y. (2013). The spectrum of lymphoblastic, nodal and extranodal T-cell lymphomas: characteristic features and diagnostic dilemmas. HUMAN PATHOLOGY, 44(4), 451-471.

Syk-Induced Phosphatidylinositol-3-Kinase Activation in EpsteinBarr Virus Posttransplant Lymphoproliferative Disorder
Hatton, O., Lambert, S. L., Phillips, L. K., Vaysberg, M., Natkunam, Y., & Martinez, O. M. (2013). Syk-Induced Phosphatidylinositol-3-Kinase Activation in EpsteinBarr Virus Posttransplant Lymphoproliferative Disorder. AMERICAN JOURNAL OF TRANSPLANTATION, 13(4), 883-890.

Integration of Genomic Medicine into Pathology Residency Training The Stanford Open Curriculum
Schrijver, I., Natkunam, Y., Galli, S., & Boyd, S. D. (2013). Integration of Genomic Medicine into Pathology Residency Training The Stanford Open Curriculum. JOURNAL OF MOLECULAR DIAGNOSTICS, 15(2), 141-148.

Selective Immunophenotyping for Diagnosis of B-cell Neoplasms: Immunohistochemistry and Flow Cytometry Strategies and Results
Boyd, S. D., Natkunam, Y., Allen, J. R., & Warnke, R. A. (2013). Selective Immunophenotyping for Diagnosis of B-cell Neoplasms: Immunohistochemistry and Flow Cytometry Strategies and Results. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 21(2), 116-131.

CD137 Ligand Is Expressed in Primary and Secondary Lymphoid Follicles and in B-cell Lymphomas Diagnostic and Therapeutic Implications
Zhao, S., Zhang, H., Xing, Y., & Natkunam, Y. (2013). CD137 Ligand Is Expressed in Primary and Secondary Lymphoid Follicles and in B-cell Lymphomas Diagnostic and Therapeutic Implications. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 37(2), 250-258.

FHIT, EGFR, and MSH2: Possible Etiopathologic, Prognostic, and Predictive Role in Non-Small Cell Lung Carcinoma in Egyptian Patients.
Younes, S. F., Aiad, H. A., Asaad, N. Y., Natkunam, Y., & Mokhtar, N. M. (2013). FHIT, EGFR, and MSH2: Possible Etiopathologic, Prognostic, and Predictive Role in Non-Small Cell Lung Carcinoma in Egyptian Patients. Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry.

Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients.
Duarte, I. X., Domeny-Duarte, P., Wludarski, S. C., Natkunam, Y., & Bacchi, C. E. (2013). Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

TdT(+) T-lymphoblastic Populations Are Increased in Castleman Disease, in Castleman Disease in Association With Follicular Dendritic Cell Tumors, and in Angioimmunoblastic T-cell Lymphoma
Ohgami, R. S., Zhao, S., Ohgami, J. K., Leavitt, M. O., Zehnder, J. L., & Warnke, R. A. (2012). TdT(+) T-lymphoblastic Populations Are Increased in Castleman Disease, in Castleman Disease in Association With Follicular Dendritic Cell Tumors, and in Angioimmunoblastic T-cell Lymphoma. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 36(11), 1619-1628.

The contribution of HGAL/GCET2 in immunohistological algorithms: a comparative study in 424 cases of nodal diffuse large B-cell lymphoma
Gualco, G., Bacchi, L. M., Domeny-Duarte, P., Natkunam, Y., & Bacchi, C. E. (2012). The contribution of HGAL/GCET2 in immunohistological algorithms: a comparative study in 424 cases of nodal diffuse large B-cell lymphoma. MODERN PATHOLOGY, 25(11), 1439-1445.

Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number
Sankaran, V. G., Ludwig, L. S., Sicinska, E., Xu, J., Bauer, D. E., & Lodish, H. F. (2012). Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number. GENES & DEVELOPMENT, 26(18), 2075-2087.

CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications
Anderson, M. W., Zhao, S., Freud, A. G., Czerwinski, D. K., Kohrt, H., & Natkunam, Y. (2012). CD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T-Cell Lymphomas Diagnostic and Therapeutic Implications. AMERICAN JOURNAL OF PATHOLOGY, 181(3), 795-803.

Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma
Cubedo, E., Gentles, A. J., Huang, C., Natkunam, Y., Bhatt, S., & Lossos, I. S. (2012). Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma. BLOOD, 119(23), 5478-5491.

LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era
Cerhan, J. R., Natkunam, Y., Morton, L. M., Maurer, M. J., Asmann, Y., & Wang, S. S. (2012). LIM domain only 2 protein expression, LMO2 germline genetic variation, and overall survival in diffuse large B-cell lymphoma in the pre-rituximab era. LEUKEMIA & LYMPHOMA, 53(6), 1105-1112.

IgG4-Related Systemic Sclerosing Disease of the Ocular Adnexa A Potential Mimic of Ocular Lymphoma
Karamchandani, J. R., Younes, S. F., Warnke, R. A., & Natkunam, Y. (2012). IgG4-Related Systemic Sclerosing Disease of the Ocular Adnexa A Potential Mimic of Ocular Lymphoma. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 137(5), 699-711.

The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases
Gualco, G., Natkunam, Y., & Bacchi, C. E. (2012). The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases. MODERN PATHOLOGY, 25(5), 661-674.

Aggressive EBV-associated Lymphoproliferative Disorder: A Prodrome to Diffuse Large B-cell Lymphoma?
Batra, R., Medeiros, B. C., Zehnder, J. L., Warnke, R. A., & Natkunam, Y. (2012). Aggressive EBV-associated Lymphoproliferative Disorder: A Prodrome to Diffuse Large B-cell Lymphoma?. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 20(3), 325-330.

Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue.
Rizvi, H., Paterson, J. C., Tedoldi, S., Ramsay, A., Calaminici, M., & Marafioti, T. (2012). Expression of the CD2AP adaptor molecule in normal, reactive and neoplastic human tissue. Pathologica, 104(2), 56-64.

Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma
Azambuja, D., Natkunam, Y., Biasoli, I., Lossos, I. S., ANDERSON, M. W., & Spector, N. (2012). Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma. ANNALS OF ONCOLOGY, 23(3), 736-742.

Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.
Morton, L. M., Cerhan, J. R., Hartge, P., Vasef, M. A., Neppalli, V. T., & Wang, S. S. (2011). Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era. International journal of molecular epidemiology and genetics, 2(3), 245-252.

Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment
Alizadeh, A. A., Gentles, A. J., Alencar, A. J., Liu, C. L., Kohrt, H. E., & Levy, R. (2011). Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. BLOOD, 118(5), 1350-1358.

Clinicopathologic and Molecular Features of 122 Brazilian Cases of Nodal and Extranodal NK/T-Cell Lymphoma, Nasal Type, With EBV Subtyping Analysis
Gualco, G., Domeny-Duarte, P., Chioato, L., Barber, G., Natkunam, Y., & Bacchi, C. E. (2011). Clinicopathologic and Molecular Features of 122 Brazilian Cases of Nodal and Extranodal NK/T-Cell Lymphoma, Nasal Type, With EBV Subtyping Analysis. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 35(8), 1195-1203.

MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
Alencar, A. J., Malumbres, R., Kozloski, G. A., Advani, R., Talreja, N., & Lossos, I. S. (2011). MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP. CLINICAL CANCER RESEARCH, 17(12), 4125-4135.

LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma
Baecklund, E., Backlin, C., Mansouri, M., Klareskog, L., Askling, J., & Rosenquist, R. (2011). LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma. LEUKEMIA & LYMPHOMA, 52(6), 1146-1149.

HGAL Protein Expression Persists in Disorders of Germinal Center Dissolution Potential Role of HGAL in the Germinal Center Microenvironment
Temmins, C., Zhao, S., Lossos, I. S., & Natkunam, Y. (2011). HGAL Protein Expression Persists in Disorders of Germinal Center Dissolution Potential Role of HGAL in the Germinal Center Microenvironment. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 19(3), 266-272.

The Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived From Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow
Younes, S. F., Beck, A. H., Ohgami, R. S., Lossos, I. S., Levy, R., & Natkunam, Y. (2011). The Efficacy of HGAL and LMO2 in the Separation of Lymphomas Derived From Small B Cells in Nodal and Extranodal Sites, Including the Bone Marrow. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 135(5), 697-708.

T-cell lymphomas: a tale of heterogeneity masking clarity
Natkunam, Y. (2011). T-cell lymphomas: a tale of heterogeneity masking clarity. LEUKEMIA & LYMPHOMA, 52(1), 1-2.

Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis
Churchill, H. Ro., Roncador, G., Warnke, R. A., & Natkunam, Y. (2010). Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis. HUMAN PATHOLOGY, 41(12), 1726-1734.

Oral and Extraoral Plasmablastic Lymphoma Similarities and Differences in Clinicopathologic Characteristics
Hansra, D., Montague, N., Stefanovic, A., Akunyili, I., Harzand, A., & Lossos, I. S. (2010). Oral and Extraoral Plasmablastic Lymphoma Similarities and Differences in Clinicopathologic Characteristics. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 134(5), 710-719.

Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse Components
Younes, S. F., Beck, A. H., Lossos, I. S., Levy, R., Warnke, R. A., & Natkunam, Y. (2010). Immunoarchitectural Patterns in Follicular Lymphoma: Efficacy of HGAL and LMO2 in the Detection of the Interfollicular and Diffuse Components. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 34(9), 1266-1276.

Expression of LMO2 Is Associated With t(14;18)/IGH-BCL2 Fusion but Not BCL6 Translocations in Diffuse Large B-Cell Lymphoma
Durnick, D. K., Law, M. E., Maurer, M. J., Natkunam, Y., Levy, R., & McPhail, E. D. (2010). Expression of LMO2 Is Associated With t(14;18)/IGH-BCL2 Fusion but Not BCL6 Translocations in Diffuse Large B-Cell Lymphoma. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 134(2), 278-281.

Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma
Sarosiek, K. A., Cavallin, L. E., Bhatt, S., Toomey, N. L., Natkunam, Y., & Lossos, I. S. (2010). Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 107(29), 13069-13074.

Embryonic Stem Cell-Derived Endothelial Cells Engraft Into the Ischemic Hindlimb and Restore Perfusion
Huang, N. F., Niiyama, H., Peter, C., De, A., Natkunam, Y., & Cooke, J. P. (2010). Embryonic Stem Cell-Derived Endothelial Cells Engraft Into the Ischemic Hindlimb and Restore Perfusion. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 30(5), 984-U224.

C-C Chemokine Receptor 1 Expression in Human Hematolymphoid Neoplasia
Anderson, M. W., Zhao, S., Ai, W. Z., Tibshirani, R., Levy, R., & Natkunam, Y. (2010). C-C Chemokine Receptor 1 Expression in Human Hematolymphoid Neoplasia. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 133(3), 473-483.

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation
Marafioti, T., Paterson, J. C., Ballabio, E., Chott, A., Natkunam, Y., & Gaulardll, P. (2010). The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 95(3), 432-439.

Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes
Metcalf, R. A., Zhao, S., Anderson, M. W., Lu, Z. S., Galperin, I., & Natkunam, Y. (2010). Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes. MODERN PATHOLOGY, 23(3), 420-433.

PD-1 Expression in T-cell Lymphomas and Reactive Lymphoid Entities: Potential Overlap in Staining Patterns Between Lymphoma and Viral Lymphadenitis
Krishnan, C., Warnke, R. A., Arber, D. A., & Natkunam, Y. (2010). PD-1 Expression in T-cell Lymphomas and Reactive Lymphoid Entities: Potential Overlap in Staining Patterns Between Lymphoma and Viral Lymphadenitis. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 34(2), 178-189.

CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas
Luo, R. F., Zhao, S., Tibshirani, R., Myklebust, J. H., Sanyal, M., & Natkunam, Y. (2010). CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas. HUMAN PATHOLOGY, 41(2), 271-280.

Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP)
Gratzinger, D., Advani, R., Zhao, S., Talreja, N., Tibshirani, R. J., & Natkunam, Y. (2010). Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP). BRITISH JOURNAL OF HAEMATOLOGY, 148(2), 235-244.

Building "tissue" microarrays from suspension cells.
Zhao, S., & Natkunam, Y. (2010). Building "tissue" microarrays from suspension cells. Methods in molecular biology (Clifton, N.J.), 664, 93-101.

Microtubule-associated Protein-2 is a Sensitive Marker of Primary and Metastatic Neuroblastoma
Krishnan, C., Higgins, J. P., West, R. B., Natkunam, Y., Heerema-McKenney, A., & Arber, D. A. (2009). Microtubule-associated Protein-2 is a Sensitive Marker of Primary and Metastatic Neuroblastoma. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 33(11), 1695-1704.

Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma
Dai, B., Zhao, X. F., Hagner, P., Shapiro, P., Mazan-Mamczarz, K., & Gartenhaus, R. B. (2009). Extracellular Signal-Regulated Kinase Positively Regulates the Oncogenic Activity of MCT-1 in Diffuse Large B-Cell Lymphoma. CANCER RESEARCH, 69(19), 7835-7843.

Characterization of c-Maf Transcription Factor in Normal and Neoplastic Hematolymphoid Tissue and Its Relevance in Plasma Cell Neoplasia
Natkunam, Y., Tedoldi, S., Paterson, J. C., Zhao, S., Rodriguez-Justo, M., & Marafloti, T. (2009). Characterization of c-Maf Transcription Factor in Normal and Neoplastic Hematolymphoid Tissue and Its Relevance in Plasma Cell Neoplasia. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 132(3), 361-371.

Immunoarchitectural Patterns in Nodal Marginal Zone B-Cell Lymphoma A Study of 51 Cases
Salama, M. E., Lossos, I. S., Warnke, R. A., & Natkunam, Y. (2009). Immunoarchitectural Patterns in Nodal Marginal Zone B-Cell Lymphoma A Study of 51 Cases. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 132(1), 39-49.

Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens
Fan, A. C., Deb-Basu, D., Orban, M. W., Gotlib, J. R., Natkunam, Y., & Felsher, D. W. (2009). Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens. NATURE MEDICINE, 15(5), 566-571.

Low Stage Follicular Lymphoma: Biologic and Clinical Characterization According to Nodal or Extranodal Primary Origin
Weinberg, O. K., Ma, L., Seo, K., Beck, A. H., Pai, R. K., & Arber, D. A. (2009). Low Stage Follicular Lymphoma: Biologic and Clinical Characterization According to Nodal or Extranodal Primary Origin. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 33(4), 591-598.

Lack of Utility of CD20 Immunohistochemistry in Staging Bone Marrow Biopsies for Diffuse Large B-cell Lymphoma
Baiyee, D., Warnke, R., & Natkunam, Y. (2009). Lack of Utility of CD20 Immunohistochemistry in Staging Bone Marrow Biopsies for Diffuse Large B-cell Lymphoma. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 17(2), 93-95.

The Transcription Factor LMO2 Is a Robust Marker of Vascular Endothelium and Vascular Neoplasms and Selected Other Entities
Gratzinger, D., Zhao, S., West, R., Rouse, R. V., Vogel, H., & Natkunam, Y. (2009). The Transcription Factor LMO2 Is a Robust Marker of Vascular Endothelium and Vascular Neoplasms and Selected Other Entities. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 131(2), 264-278.

Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France.
Quintanilla-Martinez, L., De Jong, D., de Mascarel, A., Hsi, E. D., Kluin, P., & Ott, G. (2009). Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. Journal of hematopathology, 2(4), 211-236.

Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma
Azambuja, D., Lossos, I. S., Biasoli, I., Morais, J. C., Britto, L., & Spector, N. (2009). Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma. LEUKEMIA & LYMPHOMA, 50(11), 1830-1836.

PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling
Lu, X., Malumbres, R., Shields, B., Jiang, X., Sarosiek, K. A., & Lossos, I. S. (2008). PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling. BLOOD, 112(10), 4098-4108.

Immunohistochemical characterization of nasal-type extranodal NK/T-Cell lymphoma using a tissue microarray
Schwartz, E. J., Molina-Kirsch, H., Zhao, S., Marinelli, R. J., Warnke, R. A., & Natkunam, Y. (2008). Immunohistochemical characterization of nasal-type extranodal NK/T-Cell lymphoma using a tissue microarray. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 130(3), 343-351.

Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia
Hazard, F. K., Zhao, S., Schiffman, J. D., Lacayo, N. J., Dahl, G. V., & Natkunam, Y. (2008). Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 11(4), 283-290.

Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP
Malumbres, R., Chen, J., Tibshirani, R., Johnson, N. A., Sehn, L. H., & Lossos, I. S. (2008). Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. BLOOD, 111(12), 5509-5514.

Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma
Xie, X., Sundram, U., Natkunam, Y., Kohler, S., Hoppe, R. T., & Hsi, E. D. (2008). Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma. MODERN PATHOLOGY, 21(6), 653-659.

Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis
Baecklund, E., Natkunam, Y., Backlin, C., Iliadou, A., Askling, J., & Rosenquist, R. (2008). Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis. BRITISH JOURNAL OF HAEMATOLOGY, 141(1), 69-72.

LMO2 protein expression predicts survival in patients with diffuse large B-Cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab
Natkunam, Y., Farinha, P., Hsi, E. D., Hans, C. P., Tibshirani, R., & Lossos, I. S. (2008). LMO2 protein expression predicts survival in patients with diffuse large B-Cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. JOURNAL OF CLINICAL ONCOLOGY, 26(3), 447-454.

Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy
Gratzinger, D., Zhao, S., Tibshirani, R. J., Hsi, E. D., Hans, C. P., & Natkunam, Y. (2008). Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. LABORATORY INVESTIGATION, 88(1), 38-47.

The Stanford Tissue Microarray Database
Marinelli, R. J., Montgomery, K., Liu, C. L., Shah, N. H., Prapong, W., & Ball, C. A. (2008). The Stanford Tissue Microarray Database. NUCLEIC ACIDS RESEARCH, 36, D871-D877.

Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma
Tedoldi, S., Mottok, A., Ying, J., Paterson, J. C., Cui, Y., & Marafioti, T. (2007). Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma. JOURNAL OF PATHOLOGY, 213(4), 429-440.

The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms
Jensen, K. C., Higgins, J. Pt., Montgomery, K., Kaygusuz, G., van de Rijn, M., & Natkunam, Y. (2007). The utility of PAX5 immunohistochemistry in the diagnosis of undifferentiated malignant neoplasms. MODERN PATHOLOGY, 20(8), 871-877.

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia
Rawstron, A. C., Villamor, N., Ritgen, M., Boettcher, S., Ghia, P., & Hillmen, P. (2007). International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. LEUKEMIA, 21(5), 956-964.

Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors
Lehman, N. L., Tibshirani, R., Hsu, J. Y., Natkunam, Y., Harris, B. T., & Jackson, P. K. (2007). Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. AMERICAN JOURNAL OF PATHOLOGY, 170(5), 1793-1805.

Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis
Sundram, U. N., & Natkunam, Y. (2007). Mast cell tryptase and microphthalmia transcription factor effectively discriminate cutaneous mast cell disease from myeloid leukemia cutis. JOURNAL OF CUTANEOUS PATHOLOGY, 34(4), 289-295.

Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes
Gratzinger, D., Zhao, S., Marinelli, R. J., Kapp, A. V., Tibshirani, R. J., & Natkunam, Y. (2007). Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes. AMERICAN JOURNAL OF PATHOLOGY, 170(4), 1362-1369.

The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas
Natkunam, Y., Zhao, S., Mason, D. Y., Chen, J., Taidi, B., & Levy, R. (2007). The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. BLOOD, 109(4), 1636-1642.

Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms
Natkunam, Y., Vainer, G., Chen, J., Zhao, S., Marinelli, R. J., & Lossos, I. S. (2007). Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 92(2), 176-183.

Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival
Natkunam, Y., Hsi, E. D., Aoun, P., Zhao, S., Elson, P., & Lossos, I. S. (2007). Expression of the human germinal center-associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survival. BLOOD, 109(1), 298-305.

The biology of the germinal center.
Natkunam, Y. (2007). The biology of the germinal center. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 210-215.

Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease: An immunohistochemical analysis
Morgan, T. K., Zhao, S., Chang, K. L., Haddix, T. L., Domanay, E., & Natkunam, Y. (2006). Low CD27 expression in plasma cell dyscrasias correlates with high-risk disease: An immunohistochemical analysis. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 126(4), 545-551.

EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis
Snow, A. L., Lambert, S. L., Natkunam, Y., Esquivel, C. O., Krams, S. M., & Martinez, O. M. (2006). EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis. JOURNAL OF IMMUNOLOGY, 177(5), 3283-3293.

Jaw I/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas
Tedoldi, S., Paterson, J. C., Cordell, J., Tan, S.-Y., Jones, M., & Marafioti, T. (2006). Jaw I/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas. JOURNAL OF PATHOLOGY, 209(4), 454-463.

Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice?
Natkunam, Y., & Mason, D. Y. (2006). Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice?. LABORATORY INVESTIGATION, 86(8), 742-747.

The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas
Paterson, J. C., Tedoldi, S., Craxton, A., Jones, M., Hansmann, M.-L., & Marafioti, T. (2006). The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 91(6), 772-780.

CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells
Reichard, K. K., Schwartz, E. J., Higgins, J. P., Narasimhan, B., Warnke, R. A., & Natkunam, Y. (2006). CD10 expression in peripheral T-cell lymphomas complicated by a proliferation of large B-cells. MODERN PATHOLOGY, 19(3), 337-343.

Loss of CD19 expression in B-cell neoplasms
Masir, N., Marafioti, T., Jones, M., Natkunam, Y., Rudiger, T., & Mason, D. Y. (2006). Loss of CD19 expression in B-cell neoplasms. HISTOPATHOLOGY, 48(3), 239-246.

Transmembrane adaptor molecules: a new category of lymphoid-cell markers
Tedoldi, S., Paterson, J. C., Hansmann, M. L., Natkunam, Y., Rudiger, T., & HOREJSI, V. (2006). Transmembrane adaptor molecules: a new category of lymphoid-cell markers. BLOOD, 107(1), 213-221.

Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms - A tissue microarray study of 1,754 cases
Kambham, N., Kong, C., Longacre, T. A., & Natkunam, Y. (2005). Utility of syndecan-1 (CD138) expression in the diagnosis of undifferentiated malignant neoplasms - A tissue microarray study of 1,754 cases. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 13(4), 304-310.

Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma
Troxell, M. L., Schwartz, E. J., van de Ruin, M., Ross, D. T., Warnke, R. A., & Natkunam, Y. (2005). Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 13(4), 297-303.

TMA-combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays
Liu, C. L., Montgomery, K. D., Natkunam, Y., West, R. B., Nielsen, T. O., & Higgins, J. Pt. (2005). TMA-combiner, a simple software tool to permit analysis of replicate cores on tissue microarrays. MODERN PATHOLOGY, 18(12), 1641-1648.

Cytologic diagnosis of Burkitt lymphoma.
Troxell, M. L., Bangs, C. D., Cherry, A. M., Natkunam, Y., & Kong, C. S. (2005). Cytologic diagnosis of Burkitt lymphoma. Cancer, 105(5), 310-318.

Treatment of verruca vulgaris with topical cidofovir in an immunlocompromised patient: a case report and review of the literature
Cha, S., Johnston, L., Natkunam, Y., & Brown, J. (2005). Treatment of verruca vulgaris with topical cidofovir in an immunlocompromised patient: a case report and review of the literature. TRANSPLANT INFECTIOUS DISEASE, 7(3-4), 158-161.

Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells
Verneris, M. R., Arshi, A., Edinger, M., Kornacker, M., Natkunam, Y., & Negrin, R. S. (2005). Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells. CLINICAL CANCER RESEARCH, 11(12), 4561-4570.

Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation
Natkunam, Y., Lossos, L. S., Taidi, B., Zhao, S. C., Lu, X. Q., & Levy, R. (2005). Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. BLOOD, 105(10), 3979-3986.

Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma
Marafioti, T., Pozzobon, M., Hansmann, M. L., Gaulard, P., Barth, T. F., & Mason, D. Y. (2005). Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. LEUKEMIA, 19(5), 856-861.

Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage
Nguyen, T. Dt., Schwartz, E. J., West, R. B., Warnke, R. A., Arber, D. A., & Natkunam, Y. (2005). Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 29(5), 617-624.

Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study
Sundram, U., Kim, Y., Mraz-Gernhard, S., Hoppe, R., Natkunam, Y., & Kohler, S. (2005). Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study. JOURNAL OF CUTANEOUS PATHOLOGY, 32(3), 227-234.

A novel method for making "tissue" microarrays from small numbers of suspension cells
Montgomery, K., Zhao, S. C., van de Rijn, M., & Natkunam, Y. (2005). A novel method for making "tissue" microarrays from small numbers of suspension cells. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 13(1), 80-84.

The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas
Marafiot, T., Pozzobon, M., Hansmann, M. L., Ventura, R., Pileri, S. A., & Mason, D. Y. (2005). The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. BRITISH JOURNAL OF HAEMATOLOGY, 128(3), 333-342.

Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells
Masir, N., Jones, M., Pozzobon, M., Marafioti, T., Volkova, O. Y., & Mason, D. Y. (2004). Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells. BRITISH JOURNAL OF HAEMATOLOGY, 127(3), 335-343.

Immunophenotypic and genotypic characterization of progression in follicular lymphomas
Natkunam, Y., Soslow, R., Matolcsy, A. A., Dolezal, M., Bhargava, V., & Warnke, R. (2004). Immunophenotypic and genotypic characterization of progression in follicular lymphomas. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 12(2), 97-104.

Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples
Pozzobon, M., Marafioti, T., Hansmann, M. L., Natkunam, Y., & Mason, D. Y. (2004). Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples. BRITISH JOURNAL OF HAEMATOLOGY, 124(4), 519-533.

Atypical cellular disorders.
McClain, K. L., Natkunam, Y., & Swerdlow, S. H. (2004). Atypical cellular disorders. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 283-296.

Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation
Fan, Z., Natkunam, Y., Bair, E., Tibshirani, R., & Warnke, R. A. (2003). Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 27(10), 1346-1356.

Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report
Nguyen, D. D., Loo, B. W., Tillman, G., Natkunam, Y., Cao, T. M., & Advani, R. H. (2003). Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. ANNALS OF HEMATOLOGY, 82(8), 521-525.

Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA
Sundram, U., Harvell, J. D., Rouse, R. V., & Natkunam, Y. (2003). Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA. MODERN PATHOLOGY, 16(8), 802-810.

Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas
Nepomuceno, R. R., Balatoni, C. E., Natkunam, Y., Snow, A. L., Krams, S. M., & Martinez, O. M. (2003). Rapamycin inhibits the interleukin 10 signal transduction pathway and the growth of Epstein Barr virus B-cell lymphomas. CANCER RESEARCH, 63(15), 4472-4480.

Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
Ekstrand, B. C., Lucas, J. B., Horwitz, S. M., Fan, Z., Breslin, S., & Horning, S. J. (2003). Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial. BLOOD, 101(11), 4285-4289.

Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays
Liu, C. L., Prapong, W., Natkunam, Y., Alizadeh, A., Montgomery, K., & van de Rijn, M. (2002). Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. AMERICAN JOURNAL OF PATHOLOGY, 161(5), 1557-1565.

The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens
West, R. B., Warnke, R. A., & Natkunam, Y. (2002). The usefulness of immunohistochemistry in the diagnosis of follicular lymphoma in bone marrow biopsy specimens. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 117(4), 636-643.

Epstein-Barr virus infection is associated with endothelial bcl-2 expression in transplant liver allografts
Millan, M. T., Natkunam, Y., Clarke-Katzenberg, R., Desai, D., Prapong, W., & Martinez, O. M. (2002). Epstein-Barr virus infection is associated with endothelial bcl-2 expression in transplant liver allografts. TRANSPLANTATION, 73(3), 465-469.

Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases
Harvell, J. D., Vaseghi, M., Natkunam, Y., Kohler, S., & Kim, Y. (2002). Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases. JOURNAL OF CUTANEOUS PATHOLOGY, 29(2), 88-92.

Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: Correlation with clinical outcome
Lossos, I. S., Natkunam, Y., Levy, R., & Lopez, C. D. (2002). Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: Correlation with clinical outcome. LEUKEMIA & LYMPHOMA, 43(12), 2309-2317.

Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximab
Natkunam, Y., Stanton, T. S., Warnke, R. A., & Horning, S. J. (2001). Durable remission in recurrent T-cell-rich B-cell lymphoma with the anti-CD20 antibody rituximab. CLINICAL LYMPHOMA, 2(3), 185-187.

Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation
Suryanarayan, K., Natkunam, Y., Berry, G., Bangs, C. D., Cherry, A., & Dahl, G. (2001). Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 23(7), 452-455.

A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia
Cherry, A. M., Bangs, C. D., Jones, P., Hall, S., & Natkunam, Y. (2001). A unique AML1 (CBF2A) rearrangement, t(1;21)(p32;q22), observed in a patient with acute myelomonocytic leukemia. CANCER GENETICS AND CYTOGENETICS, 129(2), 155-160.

Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma
Lossos, I. S., Jones, C. D., Warnke, R., Natkunam, Y., Kaizer, H., & Levy, R. (2001). Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. BLOOD, 98(4), 945-951.

Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry
Natkunam, Y., Warnke, R. A., Montgomery, K., Falini, B., & van de Rijn, M. (2001). Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry. MODERN PATHOLOGY, 14(7), 686-694.

Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course
Mraz-Gernhard, S., Natkunam, Y., Hoppe, R. T., Leboit, P., Kohler, S., & Kim, Y. H. (2001). Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course. JOURNAL OF CLINICAL ONCOLOGY, 19(8), 2179-2188.

Natural killer cell precursor acute lymphoma/leukemia presenting in an infant
Natkunam, Y., Cherry, A. M., & Cornbleet, P. J. (2001). Natural killer cell precursor acute lymphoma/leukemia presenting in an infant. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 125(3), 413-418.

Angiocentric lymphomas (lymphomatous vasculitis)
Natkunam, Y., & Warnke, R. A. (2001). Angiocentric lymphomas (lymphomatous vasculitis). SEMINARS IN DIAGNOSTIC PATHOLOGY, 18(1), 67-77.

Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases
Natkunam, Y., Warnke, R. A., Haghighi, B., Su, L. D., Le Boit, P. E., & Kohler, S. (2000). Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases. JOURNAL OF CUTANEOUS PATHOLOGY, 27(8), 392-399.

Blastic/blastoid transformation of follicular lymphoma - Immunohistologic and molecular analyses of five cases
Natkunam, Y., Warnke, R. A., Zehnder, J. L., Jones, C. D., Milatovich-Cherry, A., & Cornbleet, P. J. (2000). Blastic/blastoid transformation of follicular lymphoma - Immunohistologic and molecular analyses of five cases. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 24(4), 525-534.

Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrow
Natkunam, Y., & Rouse, R. V. (2000). Utility of paraffin section immunohistochemistry for C-KIT (CD117) in the differential diagnosis of systemic mast cell disease involving the bone marrow. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 24(1), 81-91.

Immunoblot analysis of CD34 expression in histologically diverse neoplasms
Natkunam, Y., Rouse, R. V., Zhu, S., Fisher, C., & van de Rijn, M. (2000). Immunoblot analysis of CD34 expression in histologically diverse neoplasms. AMERICAN JOURNAL OF PATHOLOGY, 156(1), 21-27.

Aggressive cutaneous NK and NK-like T-cell lymphomas - Clinicopathologic, immunohistochemical, and molecular analyses of 12 cases
Natkunam, Y., SMOLLER, B. R., Zehnder, J. L., Dorfman, R. F., & Warnke, R. A. (1999). Aggressive cutaneous NK and NK-like T-cell lymphomas - Clinicopathologic, immunohistochemical, and molecular analyses of 12 cases. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 23(5), 571-581.

Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation
Natkunam, Y., Warnke, R. A., Zehnder, J. L., & Cornbleet, P. J. (1999). Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 111(5), 663-671.

Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases
Natkunam, Y., ElenitobaJohnson, K. S., Kingma, D. W., & Kamel, O. W. (1997). Epstein-Barr virus strain type and latent membrane protein 1 gene deletions in lymphomas in patients with rheumatic diseases. ARTHRITIS AND RHEUMATISM, 40(6), 1152-1156.

SIMULTANEOUS ACTIVATION OF IG AND OCT-2 SYNTHESIS AND REDUCTION OF SURFACE MHC CLASS-II EXPRESSION BY IL-6
Natkunam, Y., Zhang, X. K., Liu, Z. Y., & CHENKIANG, S. (1994). SIMULTANEOUS ACTIVATION OF IG AND OCT-2 SYNTHESIS AND REDUCTION OF SURFACE MHC CLASS-II EXPRESSION BY IL-6. JOURNAL OF IMMUNOLOGY, 153(8), 3476-3484.

NUCLEAR SIGNALING BY INTERLEUKIN-6
CHENKIANG, S., Hsu, W., Natkunam, Y., & Zhang, X. K. (1993). NUCLEAR SIGNALING BY INTERLEUKIN-6. CURRENT OPINION IN IMMUNOLOGY, 5(1), 124-128.